Total Payments
$544.52
2021 Payments
$11.92
Companies
18
Transactions
26
Medicare Patients
6,773
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$532.60 (97.8%)
Education$11.92 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $532.60 | 25 | 97.8% |
| Education | $11.92 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $100.74 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $84.79 | 3 | $0 (2019) |
| Genentech USA, Inc. | $53.21 | 3 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $32.46 | 2 | $0 (2018) |
| Incyte Corporation | $30.40 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $30.29 | 2 | $0 (2019) |
| EMD Serono, Inc. | $24.88 | 1 | $0 (2020) |
| Seattle Genetics, Inc. | $23.00 | 1 | $0 (2018) |
| BTG International, Inc. | $20.55 | 1 | $0 (2017) |
| Celgene Corporation | $20.34 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $74.21 | 4 | EMD Serono, Inc. ($24.88) |
| 2019 | $114.21 | 5 | AstraZeneca Pharmaceuticals LP ($50.72) |
| 2018 | $126.38 | 7 | AstraZeneca Pharmaceuticals LP ($34.07) |
| 2017 | $217.80 | 9 | Merck Sharp & Dohme Corporation ($100.74) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 12/11/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Oncology | ||||||
| 09/18/2020 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Oncology | ||||||
| 02/21/2020 | Celgene Corporation | INREBIC (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Hematology | ||||||
| 01/24/2020 | EMD Serono, Inc. | Bavencio (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
| 10/18/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, VOTRIENT | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Hematology/Oncology | ||||||
| 03/21/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $50.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2019 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Oncology | ||||||
| 12/05/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Oncology | ||||||
| 08/17/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Oncology | ||||||
| 07/20/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 07/11/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2018 | Genentech USA, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: BioOncology | ||||||
| 04/20/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Oncology | ||||||
| 03/16/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Oncology | ||||||
| 10/20/2017 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: BioOncology | ||||||
| 10/20/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: BioOncology | ||||||
| 09/15/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $83.47 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2017 | BTG International, Inc. | VISTOGARD-20 (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: TOXICITY ANTIDOTE 5 FU TOXICITY | ||||||
| 08/18/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Oncology | ||||||
| 08/15/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Oncology | ||||||
| 05/26/2017 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), YONDELIS, ZYTIGA | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 33 | 1,469 | 20,998 | $432,963 | $91,081 |
| 2020 | 75 | 5,304 | 208,189 | $9.3M | $1.9M |
Total Patients
6,773
Total Services
229,187
Medicare Billing
$2.0M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 90 | 192 | $30,720 | $30,720 | 100.0% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 11 | 12,000 | $48,000 | $10,606 | 22.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 53 | 94 | $64,484 | $9,843 | 15.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 168 | $45,246 | $9,602 | 21.2% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2021 | 12 | 2,520 | $52,920 | $6,525 | 12.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 126 | $22,850 | $4,104 | 18.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 212 | 347 | $12,145 | $2,696 | 22.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 156 | 215 | $13,330 | $2,270 | 17.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 19 | $6,903 | $1,885 | 27.3% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 29 | 73 | $11,096 | $1,558 | 14.0% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 47 | 124 | $13,020 | $1,531 | 11.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 35 | 43 | $13,072 | $1,516 | 11.6% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 16 | 53 | $8,268 | $1,336 | 16.2% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2021 | 15 | 3,450 | $20,700 | $1,151 | 5.6% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 49 | 71 | $4,118 | $967.73 | 23.5% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 17 | 270 | $32,940 | $687.96 | 2.1% |
| 99195 | Therapeutic removal of whole blood to correct blood level imbalance | Office | 2021 | 15 | 18 | $5,530 | $641.58 | 11.6% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2021 | 23 | 25 | $3,100 | $520.25 | 16.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 136 | 159 | $3,021 | $474.00 | 15.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 16 | 22 | $1,716 | $369.60 | 21.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 12 | 25 | $2,425 | $345.86 | 14.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 16 | 18 | $1,638 | $331.02 | 20.2% |
| 83550 | Iron binding capacity | Office | 2021 | 31 | 35 | $1,190 | $305.90 | 25.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 31 | 46 | $4,278 | $287.26 | 6.7% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2021 | 14 | 26 | $1,404 | $241.80 | 17.2% |
About Dr. Harry Mccoy, M.D
Dr. Harry Mccoy, M.D is a Hematology & Oncology healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295702512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Mccoy, M.D has received a total of $544.52 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 26 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($532.60).
As a Medicare-enrolled provider, Mccoy has provided services to 6,773 Medicare beneficiaries, totaling 229,187 services with total Medicare billing of $2.0M. Data is available for 2 years (2020–2021), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Roanoke, VA
- Active Since 03/06/2006
- Last Updated 09/02/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1295702512
Products in Payments
- KEYTRUDA (Biological) $100.74
- IMFINZI (Drug) $84.79
- Bavencio (Drug) $24.88
- Avastin (Biological) $23.08
- ADCETRIS (Biological) $23.00
- Aliqopa (Drug) $20.62
- VISTOGARD-20 (Drug) $20.55
- INREBIC (Drug) $20.34
- Rubraca (Drug) $20.04
- FOUNDATIONONE (Device) $18.85
- PIQRAY (Drug) $17.67
- ONIVYDE (Drug) $16.76
- Enhertu (Drug) $16.64
- JAKAFI (Drug) $16.44
- TECENTRIQ (Biological) $15.32
- OPDIVO (Biological) $15.03
- Alecensa (Biological) $14.81
- KISQALI (Drug) $12.62
- PADCEV (Biological) $12.35
- DARZALEX (Biological) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Roanoke
Amanda Gillespie-Twardy, M.d, M.D
Hematology & Oncology — Payments: $15,362
Hematology & Oncology $15,362
Mark Kochenderfer, Md, MD
Hematology & Oncology — Payments: $12,819
Hematology & Oncology $12,819
Dr. Padmaja Mallidi, M.d, M.D
Hematology & Oncology — Payments: $1,580
Hematology & Oncology $1,580
Mrs. Kirsten Hinson, Fnp-C, FNP-C
Hematology & Oncology — Payments: $421.40
Hematology & Oncology $421.40
Joshua Morales, Md, MD
Hematology & Oncology — Payments: $412.41
Hematology & Oncology $412.41
Dr. William Fintel, M.d, M.D
Hematology & Oncology — Payments: $388.95
Hematology & Oncology $388.95